港股创新药ETF

Search documents
3900点一日游?基金公司火速解读
Xin Lang Cai Jing· 2025-10-10 10:25
智通财经10月10日讯(记者 闫军)沪指3900点"一日游",快速回落。相对而言,沪指0.94%的跌幅并不算深,科创50 与创业板指分别下跌5.61%、4.55%,成为调整最深板块。 电池、半导体跌幅居前,多只锂电池ETF、新能源ETF跌幅超7%,而集成电路ETF、科创芯片ETF等37只ETF跌幅超 6%。牛市多急跌,但这一跌幅还是让投资者有些措手不及,纷纷感慨:国庆节后开盘大涨,更应该遵循"逢高必卖"的 炒股祖训交易。 | 序 | 名称 | 现价 | 涨跌 | 涨跌幅 ▲ | 溢折率 | 成交额 | 5日涨跌幅 | 年初至今 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 锂电池ETF | 0.809 c | -0.065 | -7.44% | 0.45% | 3.75亿 | -1.22% | 64.77% | | 2 | 电池ETF嘉实 | 0.826 c | -0.065 | -7.30% | 0.54% | 3.74亿 | -0.96% | 62.92% | | 3 | 电池50ETF | 0.947 c | -0.074 ...
港股主题基金年内最高已赚155%
Bei Jing Shang Bao· 2025-10-08 15:41
Core Viewpoint - The Hong Kong stock market experienced a pullback after reaching new highs, with the Hang Seng Index and Hang Seng Tech Index both declining. Despite this, there are still optimistic projections for future growth, particularly in the technology sector, which is expected to attract investor interest [1][2]. Market Performance - As of October 8, the Hang Seng Index fell by 0.48% to 26,829.46 points, while the Hang Seng Tech Index decreased by 0.55% to 6,514.19 points. The indices had previously reached new highs on October 2, with the Hang Seng Index peaking at 27,381.84 points [1][2]. - Year-to-date, the Hang Seng Index and Hang Seng Tech Index have increased by 33.75% and 45.79%, respectively [2]. Fund Performance - Several Hong Kong-themed funds have shown outstanding performance, with some achieving returns as high as 155% in the first three quarters of the year. Notable funds include the Huatai-PineBridge Hong Kong Advantage Selected Mixed Fund and the Bank of China Hong Kong Stock Connect Pharmaceutical Mixed Fund, which reported returns of 155.14% and 126.55%, respectively [3][2]. Sector Focus - The innovative pharmaceutical sector has gained significant attention, with the China Securities Index tracking the Hong Kong Stock Connect Innovative Pharmaceutical Index showing a year-to-date increase of 118.52% [3]. - The long-term outlook for the Hong Kong market remains positive, particularly in core areas such as the internet, innovative pharmaceuticals, and medical biotechnology, which are expected to attract capital inflows [3][4]. Investment Strategy - Future investment opportunities in Hong Kong-themed funds are anticipated, especially those focusing on new economy, technology, and innovation sectors. Investors are advised to prioritize reasonably valued assets with clear growth potential and consider a systematic investment approach [4].
前三季度,这些ETF开挂了!
Sou Hu Cai Jing· 2025-10-05 02:44
来源:市场资讯 (来源:ETF万亿指数) 刚刚过去的9月,A股整体表现强势,主要指数均实现上涨,以新能源和半导体为代表的科技成长板块领跑,ETF市场也呈现出鲜明的结构性行情。 以下为主要指数和ETF行情回顾: 1、指数表现,创业板50九月领跑 9月,创业板50张14.4%,领跑主要宽基指数。创业板指涨12.0%,科创50指数涨11.5%,深证成指涨6.5%,上证指数涨0.6%,几大指数均实现月线五连 涨。 今年以来,科创创业50、科创100、科创200涨幅前三,分别张63%、59.6%、59.2%。 | 序号 指数名称 | | 今年以来 | 9月 | 8月 | 7月 | 6月 | 5月 | 4月 | 3月 | 2月 | 1月 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 涨幅 | | | | | | | | | | | 1 | 科创创办20 | 63.0% | 13.7% | 33.2% | 9.2% | 6.7% | -0.1% | -4.9% -6.0% | | 7.0% | -3.4% ...
格隆汇·十大核心ETF前三季度跑赢沪深300超20%!A500ETF基金(512050)期内涨超24%
Sou Hu Cai Jing· 2025-09-30 10:16
Market Performance - In September, the A-share market closed positively with the Shanghai Composite Index rising by 0.52%, the Shenzhen Component Index increasing by 0.35%, and the ChiNext Index remaining flat. The indices recorded gains of 0.64%, 6.54%, and 12.04% respectively for the month, marking five consecutive months of increases, with the ChiNext Index achieving a quarterly gain of over 50%, the second-best in history [1][2] Sector Performance - In September, the power equipment, non-ferrous metals, and electronics sectors led the gains, while the defense, banking, and non-bank financial sectors lagged behind [3] - For the first three quarters, the communication, electronics, power equipment, and non-ferrous metals sectors were the top performers, with the banking sector being the only one to show a decline among 31 primary industries [5] ETF Performance - The "Global Vision, Bet on China" top ten core ETFs saw a cumulative increase of 5.64% in September, with a total gain of 38.96% for the first three quarters, outperforming the CSI 300 Index by 21 percentage points [7] - The Sci-Tech Chip ETF led the gains in September with a rise of 16%, and a cumulative increase of 75.2% for the first three quarters. The ChiNext 50 ETF followed closely with a September gain of 14.53% and a cumulative increase of 59% for the year [7][8] A500 Index and ETF - The A500 ETF (512050) rose by 4.52% in September, with a cumulative gain of 24.11% for the first three quarters. The A500 Index outperformed the CSI 300 Index by over 1 percentage point in September, with a cumulative gain nearly 4 percentage points higher for the year [9][11] - The A500 Index benefits from a balanced industry distribution and a focus on growth sectors, with a significant representation of leading companies across various industries [11] ChiNext 50 ETF - The ChiNext 50 ETF closely tracks the ChiNext 50 Index, which selects the 50 largest and most liquid stocks from the ChiNext market, focusing on new energy, technology, and pharmaceuticals. The top ten weighted stocks include industry leaders such as CATL and Mindray, capturing the benefits of technological revolutions [13] Securities Sector - The securities sector experienced a sudden surge after a month of decline, likely due to the upcoming third-quarter earnings reports and increased trading activity. The average daily trading volume in A-shares reached 2.1 trillion yuan, a 67% increase from the previous month and double the year-on-year figure [16] - The securities sector saw a net inflow of over 230 billion yuan into securities-themed ETFs, with the broker ETF experiencing a net inflow of 60.3 billion yuan [16]
ETF投资高手实战大赛丨哪些ETF备受“牛人”青睐?9月30日十大买入ETF榜:半导体ETF霸榜(明细)
Xin Lang Zheng Quan· 2025-09-30 07:51
Group 1 - The "Second Golden Unicorn Best Investment Advisor Selection" event is currently ongoing, with over 3,000 professional investment advisors participating in simulated trading competitions [1] - The event aims to provide a platform for investment advisors to showcase their capabilities, expand services, and enhance skills, while also facilitating communication between outstanding advisors and the public [1] Group 2 - The top ten ETFs by buy frequency as of September 30 include the Hong Kong Securities ETF, Gaming ETF, and Hong Kong Technology 50 ETF, among others [2] - The top ten ETFs by buy amount include the Hong Kong Securities ETF, Hong Kong Technology 50 ETF, and Hong Kong Innovative Drug ETF, indicating strong investor interest in these sectors [3] Group 3 - The data for the top buy stocks/ETFs is compiled from the most frequently purchased stocks/ETFs by all participating advisors, while the buy amount data reflects the top ten by total investment [4] - The competition includes a performance evaluation segment divided into stock simulation, on-site ETF simulation, and public fund simulation, with specific trading rules regarding holding proportions, maximum drawdown, and rebalancing frequency [4]
10月金股报告:市场预计维持震荡,科技关注性价比
ZHONGTAI SECURITIES· 2025-09-26 13:12
Group 1: Market Overview - The macroeconomic environment remains supportive with expectations of further easing from the Federal Reserve, which has already lowered rates by 25 basis points in September, with projections for additional cuts by the end of the year [2] - A-shares are experiencing a high level of trading activity, with average daily turnover exceeding 2.45 trillion yuan in September, up from 2.31 trillion yuan in August, indicating strong market liquidity [2] - The technology sector continues to show strength, with the Wande Technology Index accounting for 40.8% of total A-share trading volume, reflecting ongoing liquidity inflows into this sector [2] Group 2: Sector Analysis - The technology sector is characterized by a clear differentiation between high and low performers, with previous leaders like optical modules and communication equipment seeing lower gains in September, while semiconductor materials and energy storage stocks have shown significant recovery [2][3] - Cyclical and dividend-paying stocks remain weak due to poor economic data, with various sectors underperforming compared to technology [3] - The current risk premium for A-shares is low, with the risk premium for the CSI 300 index at 5.19%, close to historical lows, suggesting limited downside potential [3] Group 3: Investment Strategy - The report recommends focusing on technology stocks with a strong price-performance ratio, particularly those that have lagged behind in previous rallies, to enhance potential returns [5] - There is an emphasis on upstream materials related to energy storage and semiconductor industries, such as lithium and cobalt, which are expected to benefit from ongoing demand growth in electric vehicles and semiconductor manufacturing [5] - The October stock selection includes a diverse range of sectors, highlighting companies in innovative pharmaceuticals, electronics, automotive, and communications, indicating a strategic approach to capitalize on sectoral strengths [10][11]
港股创新药ETF、港股创新药50ETF、通信ETF年内涨幅超100%,酒ETF、食品饮料ETF基金、煤炭ETF年内跌幅居前
Ge Long Hui· 2025-09-26 04:26
Group 1 - The core viewpoint of the article highlights the significant divergence in market performance between traditional value stocks ("老登股") and emerging technology stocks ("小登股") in the current investment landscape [8][9][10] - The term "老登股" refers to established sectors such as liquor, real estate, and coal, while "小登股" encompasses high-growth areas like AI, computing, and semiconductors [4][9] - As of September 25, 2023, the performance of various sectors shows a stark contrast, with communication and electronic sectors rising by 67.91% and 53.58% respectively, while traditional sectors like coal and food & beverage have declined by 6.70% and 5.64% [5] Group 2 - The article discusses the rise of various ETFs, with the Hong Kong Innovation Drug ETF and Communication ETF both exceeding 100% growth year-to-date, indicating strong investor interest in innovative sectors [5][6] - The commentary from industry experts suggests a shift in investment strategies, emphasizing the need to focus on high-tech sectors for future growth, as traditional sectors may not sustain long-term market leadership [11][12] - The ongoing market dynamics reflect a fundamental change in investor sentiment, with a growing preference for technology-driven investments over traditional value stocks [10][12]
港股创新药ETF(513120)收涨2.29% 为全市场规模最大的创新药主题基金
Xin Lang Cai Jing· 2025-09-22 12:46
来源:中证网 多家机构持续看好创新药后市表现。东吴证券认为,在美联储降息背景下,国内外投融资有望回暖,创 新产业链景气度持续提升。国金证券认为创新药产业向上趋势不变,通过BD引进管线弥补收入缺口的 战略未来有望持续。华鑫证券认为,中国创新药出海是创新成果持续涌现和创新效率驱动的结果,短期 内或有波动,但全年增长的趋势不变。(张舒琳) 港股创新药ETF(513120,联接A/C类:019670/019671)跟踪中证香港创新药指数,一键打包港股创新 药产业龙头,前十大成分股权重超70%,创新药(生物制品+化学制药)含量超90%。该ETF支持T+0交 易,9月以来日均成交额超109亿元。 中证网讯 9月22日,港股整体回调震荡,创新药板块持续走强,全市场规模最大的港股创新药ETF (513120)收涨2.29%,单日成交额超71亿元,截至9月21日最新规模超247亿元,是全市场规模最大、 交投最活跃的创新药主题基金。截至9月21日,该ETF今年以来涨超107%,居Wind二级同类第一名;持 有人户数上半年净增长3.47万户,截至上半年末为8.76万户,增量居同类第一名,其中机构投资者持有 69.43亿份,机构持有 ...
我,投资人,打算在港股IPO博个未来
Hu Xiu· 2025-09-22 08:58
Core Viewpoint - The recent bull market in Hong Kong's innovative drug sector has led to inflated valuations and speculative behavior among companies seeking IPOs, raising concerns about potential valuation bubbles in the market [2][9]. Group 1: Market Dynamics - The Hong Kong stock market has seen a surge, prompting companies to rapidly seek funding and IPO opportunities [2][3]. - Companies are increasingly claiming to be on the verge of IPOs, with some even inflating their business models to attract investment [4][5]. - The lack of clear IPO standards in Hong Kong has made it challenging for investors to assess the true value of companies [4][6]. Group 2: Investment Behavior - Investors are exhibiting a frenzied approach to funding, with some willing to invest without negotiating terms, driven by the fear of missing out on potential gains [4][7]. - There are reports of companies engaging in practices like mini IPOs to manipulate market perception and maintain valuations [7][8]. - The phenomenon of companies inflating their valuations post-IPO has led to significant market volatility, with some stocks experiencing drastic declines shortly after listing [8][9]. Group 3: Future Outlook - Companies in the innovative drug sector are optimistic about their prospects, with many planning to increase their valuations in anticipation of future market conditions [9]. - There is uncertainty regarding when the current valuation bubble in the Hong Kong innovative drug sector will burst, as companies continue to chase inflated market expectations [9][10].
一颗“新药”引爆板块!
Di Yi Cai Jing Zi Xun· 2025-09-17 13:55
港股创新药板块近期上演了一场罕见的"心跳"行情。 药捷安康-B(2617.HK,下称"药捷安康")前一天刚玩完"暴涨63%又闪崩收跌"的蹦极走势,多只港股 创新药ETF又在9月17日开盘时,就"霸榜"跨境ETF跌幅榜,多只产品跌超1%。 这家刚上市不足三个月、还没一分钱营收的生物制药公司,短短六天股价飙涨超550%,甚至一举跻身 千亿市值俱乐部,更火速被纳入多只指数成分股,引得指数产品被动"上车",同时引发"凭什么?"的广 泛争议。 剧烈波动背后,不仅ETF投资者很"受伤",创新药投资的高风险特性再次引人深思。有指数投研人士受 访称,核心争议在于,为什么一只上市不到三个月、尚无业绩支撑的新股,可以被纳入指数成分股,且 占据了不低的比重。 而相关基金公司人士向第一财经透露,事件发生后,已和指数公司进行沟通。 港股创新药ETF领跌 9月17日,港股创新药主题ETF早盘即陷入调整,并占领跨境ETF的跌幅榜。截至收盘,银华国证港股 通创新药ETF下跌2.98%,位居跌幅榜首;汇添富国证港股通创新药ETF同样下跌2.29%;此外,博时恒 生港股通创新药精选ETF、工银国证港股通创新药ETF等多只产品跟跌,跌幅均超1%。 ...